polaris retatrutide Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide to Weight Loss, Appetite Control & Metabolic Reset What Is the Starting Dose

Based on Phase 2 trial data, the most common side effects are gastrointestinal, including nausea, vomiting, diarrhoea, and constipation, which are most pronounced during dose escalation

5 Conclusion In conclusion, the expanding body of evidence supports that GLP-1RAs offer a multifaceted approach to ocular therapeutics by targeting key molecular pathways involved in retinal neuroprotection, mitochondrial regulation, inflammation, vascular remodeling, and angiogenesis

These symptoms, along with reduced caloric intake, may cause fatigue, dehydration, or electrolyte imbalances that could paradoxically worsen brain fog in some individuals

But it tends to keep GLP-1 elevated longer, which helps with appetite control well beyond the meal itself